Healthcare ETFs
XBI — SPDR S&P Biotech ETF
SPDR · S&P Biotechnology Select · since 2006
Equal-weighted biotech dominated by small-cap clinical-stage names. Very high beta.
- Expense ratio
- 0.35%
- AUM
- $6.2B
- Dividend yield
- 0.0%
- 1Y return
- +19.4%
- 3Y ann.
- +2.1%
- 5Y ann.
- -3.6%
- 10Y ann.
- —
- Since inception
- —
Top holdings
- Insmed2.40%
- Alnylam2.10%
- United Therapeutics2.00%
- Halozyme1.90%
- Exelixis1.80%
140 total holdings · 17.0% in the top 10